These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33231843)

  • 21. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.
    López-Chiriboga AS; Majed M; Fryer J; Dubey D; McKeon A; Flanagan EP; Jitprapaikulsan J; Kothapalli N; Tillema JM; Chen J; Weinshenker B; Wingerchuk D; Sagen J; Gadoth A; Lennon VA; Keegan BM; Lucchinetti C; Pittock SJ
    JAMA Neurol; 2018 Nov; 75(11):1355-1363. PubMed ID: 30014148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelin Oligodendrocyte Glycoprotein Antibody Persistency in a Steroid-Dependent ADEM Case.
    Polat İ; Yiş U; Karaoğlu P; Ayanoğlu M; Öztürk T; Güleryüz H; Kurul SH
    Pediatrics; 2016 May; 137(5):. PubMed ID: 27244783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing.
    Sechi E; Buciuc M; Pittock SJ; Chen JJ; Fryer JP; Jenkins SM; Budhram A; Weinshenker BG; Lopez-Chiriboga AS; Tillema JM; McKeon A; Mills JR; Tobin WO; Flanagan EP
    JAMA Neurol; 2021 Jun; 78(6):741-746. PubMed ID: 33900394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High titers of myelin oligodendrocyte glycoprotein antibody are only observed close to clinical events in pediatrics.
    Lui A; Chong J; Flanagan E; Abrams AW; Krysko KM; Arikan B; Francisco C; Rutatangwa A; Waubant E; Ziaei A
    Mult Scler Relat Disord; 2021 Nov; 56():103253. PubMed ID: 34517190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics of myelin oligodendrocyte glycoprotein antibody neuromyelitis optica spectrum disorder.
    Salama S; Pardo S; Levy M
    Mult Scler Relat Disord; 2019 May; 30():231-235. PubMed ID: 30825703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MOG Spectrum Disorders and Role of MOG-Antibodies in Clinical Practice.
    Hennes EM; Baumann M; Lechner C; Rostásy K
    Neuropediatrics; 2018 Feb; 49(1):3-11. PubMed ID: 28859212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.
    Jitprapaikulsan J; Chen JJ; Flanagan EP; Tobin WO; Fryer JP; Weinshenker BG; McKeon A; Lennon VA; Leavitt JA; Tillema JM; Lucchinetti C; Keegan BM; Kantarci O; Khanna C; Jenkins SM; Spears GM; Sagan J; Pittock SJ
    Ophthalmology; 2018 Oct; 125(10):1628-1637. PubMed ID: 29716788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.
    Chen JJ; Flanagan EP; Jitprapaikulsan J; López-Chiriboga ASS; Fryer JP; Leavitt JA; Weinshenker BG; McKeon A; Tillema JM; Lennon VA; Tobin WO; Keegan BM; Lucchinetti CF; Kantarci OH; McClelland CM; Lee MS; Bennett JL; Pelak VS; Chen Y; VanStavern G; Adesina OO; Eggenberger ER; Acierno MD; Wingerchuk DM; Brazis PW; Sagen J; Pittock SJ
    Am J Ophthalmol; 2018 Nov; 195():8-15. PubMed ID: 30055153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.
    Chen JJ; Tobin WO; Majed M; Jitprapaikulsan J; Fryer JP; Leavitt JA; Flanagan EP; McKeon A; Pittock SJ
    JAMA Ophthalmol; 2018 Apr; 136(4):419-422. PubMed ID: 29470571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Postpartum Period Can Worsen Myelin Oligodendrocyte Glycoprotein Antibody-associated Encephalomyelitis.
    Yamamoto S; Yano M; Miyamoto Y; Hanaoka T; Nishida Y; Kawano Y
    Intern Med; 2023 Apr; 62(7):1063-1066. PubMed ID: 36070939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients.
    Zhao Y; Tan S; Chan TCY; Xu Q; Zhao J; Teng D; Fu H; Wei S
    Br J Ophthalmol; 2018 Oct; 102(10):1372-1377. PubMed ID: 29363529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination.
    Tea F; Lopez JA; Ramanathan S; Merheb V; Lee FXZ; Zou A; Pilli D; Patrick E; van der Walt A; Monif M; Tantsis EM; Yiu EM; Vucic S; Henderson APD; Fok A; Fraser CL; Lechner-Scott J; Reddel SW; Broadley S; Barnett MH; Brown DA; Lunemann JD; Dale RC; Brilot F;
    Acta Neuropathol Commun; 2019 Sep; 7(1):145. PubMed ID: 31481127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late-onset acute disseminated encephalomyelitis followed by optic neuritis without anti-myelin oligodendrocyte glycoprotein antibodies: a biopsied case report.
    Mori M; Sakai K; Tada Y; Nozaki I; Usui Y; Ichinose T; Tanaka S; Takahashi T; Nakada M; Yamada M
    Neurol Sci; 2021 Nov; 42(11):4731-4735. PubMed ID: 34170431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolated seizures during the first episode of relapsing myelin oligodendrocyte glycoprotein antibody-associated demyelination in children.
    Ramanathan S; O'grady GL; Malone S; Spooner CG; Brown DA; Gill D; Brilot F; Dale RC
    Dev Med Child Neurol; 2019 May; 61(5):610-614. PubMed ID: 30221764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008‒2018: A nationwide, population-based cohort study.
    Boesen MS; Jensen PEH; Born AP; Magyari M; Nilsson AC; Hoei-Hansen C; Blinkenberg M; Sellebjerg F
    Mult Scler Relat Disord; 2019 Aug; 33():162-167. PubMed ID: 31276927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic features of initial demyelinating events associated with serum MOG-IgG.
    Orlandi R; Mariotto S; Ferrari S; Gobbin F; Sechi E; Capra R; Mancinelli CR; Bombardi R; Zuliani L; Zoccarato M; Rossi F; Camera V; Ferraro D; Benedetti MD; Reindl M; Gajofatto A
    J Neuroimmunol; 2020 Jul; 344():577260. PubMed ID: 32442864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follow-up study on Chinese children with relapsing MOG-IgG-associated central nervous system demyelination.
    Zhou J; Lu X; Zhang Y; Ji T; Jin Y; Xu M; Bao X; Zhang Y; Xiong H; Chang X; Jiang Y; Wu Y
    Mult Scler Relat Disord; 2019 Feb; 28():4-10. PubMed ID: 30529926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.
    Jarius S; Pellkofer H; Siebert N; Korporal-Kuhnke M; Hümmert MW; Ringelstein M; Rommer PS; Ayzenberg I; Ruprecht K; Klotz L; Asgari N; Zrzavy T; Höftberger R; Tobia R; Buttmann M; Fechner K; Schanda K; Weber M; Asseyer S; Haas J; Lechner C; Kleiter I; Aktas O; Trebst C; Rostasy K; Reindl M; Kümpfel T; Paul F; Wildemann B;
    J Neuroinflammation; 2020 Sep; 17(1):261. PubMed ID: 32883348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases.
    Serguera C; Stimmer L; Fovet CM; Horellou P; Contreras V; Tchitchek N; Massonneau J; Leroy C; Perrin A; Flament J; Hantraye P; Demilly J; Marignier R; Chrétien P; Hart B; Boutonnat J; Adam C; Le-Grand R; Deiva K
    J Neuroinflammation; 2019 Nov; 16(1):244. PubMed ID: 31785610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes.
    Sepúlveda M; Armangue T; Martinez-Hernandez E; Arrambide G; Sola-Valls N; Sabater L; Téllez N; Midaglia L; Ariño H; Peschl P; Reindl M; Rovira A; Montalban X; Blanco Y; Dalmau J; Graus F; Saiz A
    J Neurol; 2016 Jul; 263(7):1349-60. PubMed ID: 27147513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.